Pleural effusion is fluid collecting between the two membranes that line the lungs and chest wall; empyema is the specific situation where that fluid becomes infected and turns to pus. The distinction matters because a simple effusion often resolves on its own or with treatment of the underlying cause, while empyema almost always requires drainage and can become life-threatening if it goes unrecognized. What complicates the picture is that these are not entirely separate diseases. When pneumonia triggers fluid buildup in the pleural space, that fluid can progress through a continuum, from a harmless “sympathetic” effusion to a complicated, infected collection and finally to frank empyema, sometimes within days.
A Spectrum, Not a Switch
Doctors describe pleural infection as a spectrum of conditions rather than a clean binary. A simple parapneumonic effusion is sterile fluid that appears alongside pneumonia, essentially an inflammatory reaction to nearby infection. As bacteria invade the pleural space, the fluid chemistry shifts: glucose drops, acidity rises, and proteins accumulate. At this stage the effusion is labeled “complicated.” Empyema is the endpoint, defined by visibly purulent fluid or a positive bacterial culture from the pleural space.1Elsevier / Clinics in Chest Medicine. Pleural Infection The clinical challenge is that no single bright line separates one stage from the next; they blend together, and a patient can slide from uncomplicated to complicated between two imaging studies.
How Doctors Classify the Fluid
The first diagnostic fork is whether an effusion is a transudate or an exudate. Transudates are watery, protein-poor fluids pushed into the pleural space by pressure imbalances, most often from heart failure, liver cirrhosis, or kidney disease. Exudates are protein-rich fluids driven by inflammation or infection, the category that includes parapneumonic effusions and empyema. Light’s criteria, a set of lab thresholds comparing protein and enzyme levels in the fluid to those in the blood, remain the standard tool for making this call, with accuracy around 95%.2PubMed. A study of Light’s criteria and possible modifications for distinguishing exudative from transudative pleural effusions One well-known limitation is that patients on diuretics for heart failure sometimes produce fluid that meets exudate criteria even though the underlying problem is a transudate; roughly one in five such patients gets misclassified.3PubMed Central. Comparison of the Efficacy of Light’s Criteria With Serum-Effusion Albumin Gradient and Pleural Effusion Glucose
Once an effusion is confirmed as exudative and tied to pneumonia, the real question is how far along the infection has progressed. This is where fluid pH and glucose become critical. A pH below 7.2, a glucose level under 60 mg/dL, and an LDH above 1,000 IU/dL together signal that an empyema is forming and that the fluid needs to come out.4The American Journal of Surgery. Pleural fluid pH: Diagnostic, therapeutic, and prognostic value A pH above 7.3 generally means the effusion is uncomplicated and can be watched rather than drained. The gray zone between 7.2 and 7.3 calls for repeated sampling and close observation. Guidelines also recommend drainage when the fluid fills half or more of the chest cavity, when imaging shows internal walls or pockets forming inside the fluid (loculations), when Gram stain or culture is positive, or when the fluid looks frankly purulent.5PubMed. Parapneumonic pleural effusions and empyema in adults: current practice
What Imaging Reveals
A plain chest X-ray can show that fluid is present but tells you little about whether it is infected. Ultrasound and CT scanning do far more. Bedside ultrasound has become the go-to first-line tool because it is fast, radiation-free, and better than CT at detecting the internal septations and pockets that suggest complicated disease. One comparative study found that ultrasound picked up septations in about 85% of empyema cases versus 60% for contrast-enhanced CT, and loculations in about 83% versus 65%.6International Journal of Medical and All Body Health Research. Comparative Analysis of Thoracic Ultrasound and Contrast-Enhanced CT in Diagnosing Pleural Empyema: A Cross Sectional Study Ultrasound also guides needle placement in real time, reducing the risk of complications during drainage.
CT still plays a role when the picture is unclear or when surgeons need a road map before operating. The “split pleura sign,” where both the inner and outer pleural membranes light up after contrast injection with fluid trapped between them, is a strong indicator that the effusion is complicated or has progressed to empyema. When the split pleura sign appears alongside a sizable fluid collection, the combination carries roughly 80% sensitivity and 80% specificity for complicated disease or empyema.7PLOS ONE. A Simple Method for Differentiating Complicated Parapneumonic Effusion/Empyema from Parapneumonic Effusion Using the Split Pleura Sign and the Amount of Pleural Effusion on Thoracic CT CT is also the best tool for telling empyema apart from a lung abscess, a distinction that changes treatment entirely. The most reliable CT features for this are wall characteristics, the way the pleural layers separate, and whether adjacent lung tissue is compressed rather than destroyed.8PubMed. Differentiating lung abscess and empyema: radiography and computed tomography
The Bacteria Behind the Infection
Not every pleural effusion is infected, but when bacteria are involved, the microbiology matters for treatment. The organisms causing empyema differ depending on whether the infection was picked up in the community or in a hospital. Community-acquired empyema is heavily driven by mouth and throat bacteria, particularly the Streptococcus species that live in the gums and tonsils. Classic work in this area found anaerobic bacteria, alone or mixed with other organisms, in about 70% of empyema cases, with a strong link to poor dental health and aspiration of oral secretions into the lungs.9Oxford Academic (Clinical Infectious Diseases). Pleural Empyema: Etiology and Pathogenesis Hospital-acquired empyema tends to involve more drug-resistant organisms, including methicillin-resistant Staphylococcus aureus (MRSA) and gram-negative bacteria, and carries a worse prognosis.
Because many of these bacteria are difficult to culture using standard techniques, a substantial fraction of empyema cases come back “culture-negative.” Modern molecular methods, such as testing for bacterial DNA in the fluid, catch more pathogens but are not universally available. This matters practically because empiric antibiotic regimens need to cover anaerobes and streptococci as a baseline while hospital-acquired cases may require broader coverage.
Antibiotic Penetration Into the Pleural Space
A longstanding worry has been that antibiotics might not reach adequate concentrations inside infected pleural fluid, especially when the fluid is thick and acidic. Recent pharmacokinetic data are reassuring on this point. A study measuring multiple common antibiotics in infected effusions found that all tested drugs except co-trimoxazole reached pleural fluid levels comparable to blood levels and well above the concentrations needed to kill relevant bacteria.10Thorax. Antibiotic pharmacokinetics in infected pleural effusions Moxifloxacin, a fluoroquinolone, also penetrates well into both infected and non-infected effusions, though the drug takes longer to reach peak levels when the fluid is infected.11PubMed Central. Moxifloxacin pharmacokinetics and pleural fluid penetration in patients with pleural effusion The practical takeaway is that antibiotic choice should be guided by the likely organisms, not by fear that the drugs will not get where they need to go.
When Drainage Is Needed and How It Is Done
Simple parapneumonic effusions usually do not need drainage. Antibiotics treat the pneumonia, the inflammation resolves, and the fluid reabsorbs. But once an effusion crosses into complicated territory, or pus is present, the fluid must come out. No antibiotic can sterilize a walled-off collection of pus from the bloodstream alone. The question is how to get it out.
Small-bore pigtail catheters, which are flexible tubes about 4 mm in diameter placed through the chest wall under image guidance, are less painful and easier to manage than traditional large-bore chest tubes. They work well for free-flowing infected fluid and cause less damage to surrounding structures.12PubMed Central. Percutaneous management of complicated empyema thoracis using pigtail, report of a case from University Hospital of Nepal: a case report Their disadvantage is that they clog more easily with thick, viscous pus. In one pediatric comparison, treatment failure was significantly higher with pigtail catheters than with larger tube thoracostomy, at about 43% versus 14%.13PubMed. Percutaneous pigtail catheter versus tube thoracostomy for pediatric empyema: A comparison of outcomes The best approach often depends on how thick the fluid is and whether there are septations walling off pockets that a single catheter cannot reach.
Intrapleural Enzyme Therapy
When infected fluid is divided into pockets by fibrous strands, even a well-placed drain may not clear the space. For these cases, doctors can instill a combination of two drugs directly through the chest tube: tissue plasminogen activator (tPA), which dissolves the fibrin strands creating the pockets, and DNase, an enzyme that breaks down the sticky DNA released by dying white blood cells. The landmark trial on this combination showed that tPA and DNase together reduced the amount of fluid on chest imaging by about 30% compared to roughly 17% with placebo, cut hospital stays by nearly a week, and reduced the need for surgical referral from about 16% to 4%.14PubMed. Intrapleural use of tissue plasminogen activator and DNase in pleural infection Neither drug worked well alone; the effect depended on using both together.
Subsequent experience has explored whether lower doses can achieve similar results. One series treating complicated effusions and empyema reported successful resolution with medical therapy alone in 80% of patients, using lower cumulative doses of both agents and typically only two treatment cycles.15PubMed Central. Rethinking the Doses of Tissue Plasminogen Activator and Deoxyribonuclease Administrated Concurrently for Intrapleural Therapy for Complicated Pleural Effusion and Empyema No hemorrhagic complications were reported with the lower-dose approach. The field is still working out the optimal protocol, but combined tPA-DNase has become a standard step before considering surgery when drainage alone is failing.
When Surgery Becomes Necessary
Empyema progresses through three recognized phases. The first (exudative) phase involves free-flowing infected fluid. The second (fibrinopurulent) phase involves loculated, thickening fluid. The third (organizing) phase involves a solid rind of scar tissue that encases the lung and prevents it from expanding, sometimes called a “trapped lung.” Surgery to peel away this rind, known as decortication, is the definitive treatment for organizing empyema.
Video-assisted thoracoscopic surgery (VATS) has largely replaced open thoracotomy for this purpose. Even in advanced cases that historically required open surgery, VATS decortication is feasible and offers the benefits of a minimally invasive approach with reasonable operating times.16Journal of the Egyptian Society of Cardio-Thoracic Surgery. Thoracoscopic decortication for stage III empyema; a minimal invasive approach in a delayed presentation disease Surgeons require roughly 40 cases to become proficient enough to achieve optimal operating times.17PubMed Central. Lung decortication in phase III pleural empyema by video-assisted thoracoscopic surgery (VATS)-results of a learning curve study However, conversion to open surgery is still sometimes needed, particularly in chronic empyema that has been present for more than three weeks. In one large series, about 46% of patients with chronic empyema needed conversion from VATS to an open procedure.18Chest / ScienceDirect. Thoracoscopy for Empyema and Hemothorax
Timing is critical. A study analyzing outcomes of VATS decortication for chronic empyema found that delaying surgery beyond about seven and a half days after hospital admission tripled the 90-day mortality rate, from roughly 14% to 45%.19PubMed Central. Optimal timing for video assisted thoracic surgery decortication for improved survival in chronic empyema Older age, kidney failure, and a pleural fluid pH at or below 7.2 were additional independent risk factors for poor surgical outcomes.
Predicting Who Will Do Poorly
Not everyone with pleural infection faces the same risk. The RAPID score, which stands for Renal function (urea), Age, fluid Purulence, Infection source, and Dietary status (albumin), was developed to stratify patients into low, medium, and high risk categories. In a large prospective validation, three-month mortality was about 2% for low-risk patients, roughly 9% for medium-risk, and about 29% for high-risk patients.20European Respiratory Journal. Prospective validation of the RAPID clinical risk prediction score in adult patients with pleural infection: the PILOT study Higher risk categories also predicted longer hospital stays and higher costs.21PubMed. Risk Stratification in Patients with Complicated Parapneumonic Effusions and Empyema Using the RAPID Score The score is designed to identify patients who need aggressive early treatment and close monitoring, though its performance is strongest in bacterial empyema as opposed to tuberculous cases.22PubMed Central. Utility of RAPID score in parapneumonic effusion or empyema: A prospective study at a tertiary centre
The Tuberculosis Wrinkle
In much of the world, tuberculosis (TB) is a major cause of pleural effusion that sits outside the standard parapneumonic-to-empyema progression. TB effusions are typically exudative and lymphocyte-rich, and they behave differently from typical bacterial infections. The diagnosis is often made by measuring adenosine deaminase (ADA) in the pleural fluid. In TB effusions, the median ADA level is many times higher than in non-TB effusions, and the test performs well as a diagnostic screen in high-burden settings.23PubMed Central. Diagnostic Performance of Pleural Fluid Adenosine Deaminase for Tuberculous Pleural Effusion in a Low-Incidence Setting The catch is that ADA can also be elevated in empyema, certain cancers, and rheumatoid pleurisy, so a high reading does not automatically mean TB, especially in areas where bacterial empyema is common.24PLoS ONE. Adenosine deaminase for diagnosis of tuberculous pleural effusion: A systematic review and meta-analysis Clinicians in areas where both TB and bacterial pneumonia are prevalent have to weigh ADA results alongside other findings to avoid misdiagnosis.
Empyema in Children
Empyema complicating pneumonia is a significant problem in children, though it carries lower mortality than in adults. Management decisions, particularly around antibiotic regimens and drainage, remain a matter of active debate.25PubMed Central. Parapneumonic empyema in children: a scoping review of the literature The microbiology differs somewhat from adults. In a large German surveillance study of over 1,400 children with parapneumonic effusion or empyema, Streptococcus pneumoniae and Streptococcus pyogenes were the dominant organisms, with Staphylococcus aureus less common but showing a concerning 31% rate of methicillin resistance. The study also highlighted widespread antibiotic overtreatment: children given combination antibiotic regimens did not show better outcomes than those on single agents, and even when a specific pathogen was identified, only a small fraction of patients had their therapy narrowed appropriately.26PubMed Central. Empiric Antibiotic Therapy in 1402 Children With Parapneumonic Effusion/Pleural Empyema in Germany: A Long-term Surveillance Study
The good news for children is that long-term outcomes are generally favorable. One follow-up study performed an average of eight years after childhood empyema found that all patients had normal physical examinations and about 80% had normal lung-function testing, though half reported lingering symptoms like reduced exercise tolerance or prolonged coughs after colds.27PubMed. Long-term recovery after parapneumonic empyema in children Chest imaging, especially MRI, continued to show pleural scarring in the majority, but this mostly did not translate into functional impairment. Another study found that lung function and radiological abnormalities typically resolve within about two to three months of hospital discharge, though with wide individual variation.28PubMed. Clinical, functional, and radiological outcome in children with pleural empyema
New Biomarkers on the Horizon
The standard lab tests for deciding whether a parapneumonic effusion is infected, fluid pH, glucose, and LDH, are well-established but imperfect. Researchers have been investigating whether newer blood and fluid markers might improve diagnostic accuracy. Pleural fluid C-reactive protein (CRP) and a marker called sTREM-1 both showed greater than 70% accuracy for distinguishing infected from non-infected effusions, though neither consistently outperformed conventional LDH measurements.29PubMed Central. Evaluation of biomarkers sTREM-1, procalcitonin and C reactive protein in the diagnosis of pleural infection Procalcitonin, which is widely used to guide antibiotic decisions in pneumonia, has proven disappointing in pleural fluid, performing no better than chance in at least one head-to-head comparison with CRP.30PubMed Central. Diagnostic Utility of Pleural C-Reactive Protein and Procalcitonin for Parapneumonic Pleural Effusion: A Head-to-Head Comparison Study For now, the classic fluid chemistry panel remains the most practical and reliable approach, but CRP in the pleural fluid may become a useful addition, especially when pH measurement is unavailable.
A Problem Recognized for Millennia
Hippocrates described draining infected pleural fluid over 2,000 years ago, making empyema one of the oldest recognized surgical diseases. The modern era of closed chest drainage, where a sealed system prevents air from entering while allowing fluid to exit, took shape during the 1917–1919 influenza pandemic, when post-pneumonic empyema was devastatingly common.31European Respiratory Review. Empyema thoracis: new insights into an old disease Closed drainage systems were later refined through the twentieth century and remain the backbone of modern pleural management.32PubMed Central. Chest Tubes and Pleural Drainage: History and Current Status in Pleural Disease Management What has changed dramatically is the ability to intervene earlier, image the problem in real time, dissolve internal barriers with enzymes, and operate through tiny incisions rather than cracking the chest open. The fundamental principle, however, has not changed since ancient Greece: infected fluid trapped in a closed space will not get better until you let it out.